Why Alpha Tau Medical Shares Are Rising Today
Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares are trading higher after the company announced FDA approval of its IDE application to initiate its multi-center pivotal study for the treatment of recurrent cutaneous Squamous Cell Carcinoma using the Alpha DaRT.
Benzinga ·